Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Vox Sang ; 112(3): 201-209, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28198026

RESUMEN

BACKGROUND: Although most studies have shown that little haemolysis is induced by infusion pumps, there are some notable exceptions. Only limited data are available on the actual infusion pumps that are most used in hospitals in Quebec and elsewhere, namely, the Infusomat® Space (peristaltic), Plum A+™ (piston) and Colleague® CXE (shuttle) pumps. METHODS: Haemolysis and potassium levels were compared before and after the use of the three different infusion pumps. Using 135 units of packed red blood cells (RBCs) aged from 10 to 28 days, 27 measurements were taken for each pump at various flow rates (30, 60, 150, 300 and 450 ml/h) and were compared with measurements taken before using the pumps. The range of flow rates was chosen to cover those of paediatric and adult transfusions. RESULTS: The shuttle- and piston-type pumps resulted in low haemolysis levels. The peristaltic-type pump produced significantly more haemolysis, which worsened at low flow rates, but the absolute value of haemolysis remained within the range recommended by the regulatory agencies in North America and Europe. Approximately two-thirds of the haemolysis produced by the peristaltic-type pump seemed to be secondary to the use of an antisiphon valve (ASV) on the transfusion line recommended by the manufacturer. Potassium levels did not increase with the use of the pumps. CONCLUSION: Modern infusion pumps widely used in hospitals in Quebec and elsewhere produce non-threatening levels of haemolysis during the transfusion of packed RBCs aged from 10 to 28 days. ASVs appear to induce additional haemolysis, and we do not recommend using them for blood transfusion.


Asunto(s)
Transfusión de Eritrocitos/instrumentación , Bombas de Infusión , Transfusión de Eritrocitos/métodos , Eritrocitos/citología , Eritrocitos/metabolismo , Hematócrito , Hemoglobinas/análisis , Hemólisis , Humanos , Potasio/análisis , Resistencia al Corte , Factores de Tiempo
2.
Vox Sang ; 111(4): 341-349, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27280338

RESUMEN

BACKGROUND AND OBJECTIVES: Fluid warmers are routinely used to reduce the risk of hypothermia and cardiac complications associated with the infusion of cold blood products. However, warming blood products could generate haemolysis. This study was undertaken to compare the impact of temperature of blood warmers on the per cent haemolysis of packed red blood cells (RBCs) heated at different flow rates as well as non-flow conditions. MATERIALS AND METHODS: Infusion warmers used were calibrated at 41·5°C ± 0·5°C and 37·5°C ± 0·5°C. Cold RBC units stored at 4°C in AS-3 (n = 30), aged 30-39 days old, were divided into half units before being allocated under two different scenarios (i.e. infusion pump or syringe). RESULTS: Blood warmers were effective to warm cold RBCs to 37·5°C or 41·5°C when used in conjunction with an infusion pump at flow rate up to 600 ml/h. However, when the warmed blood was held in a syringe for various periods of time, such as may occur in neonatal transfusions, the final temperature was below the expected requirements with measurement as low as 33·1°C. Increasing the flow with an infusion pump increased haemolysis in RBCs from 0·2% to up to 2·1% at a flow rate of 600 ml/h regardless of the warming device used (P < 0·05). No relevant increase of haemolysis was observed using a syringe. CONCLUSIONS: The use of a blood warmer adjusted to 41·5°C is probably the best choice for reducing the risk of hypothermia for the patient without generating haemolysis. However, we should be cautious with the use of an infusion pump for RBC transfusion, particularly at high flow rates.


Asunto(s)
Transfusión Sanguínea/métodos , Eritrocitos/fisiología , Hemólisis , Seguridad de la Sangre , Supervivencia Celular , Recuento de Eritrocitos , Humanos , Temperatura
3.
Curr Oncol ; 16(5): 84-6, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19862366

RESUMEN

Bevacizumab is currently approved in association with first- and second-line 5-fluorouracil-based chemotherapy regimens for patients with metastatic colorectal cancer. Few data about the usefulness of bevacizumab in third-line settings are available. We describe a patient refractory to FOLFIRI and FOLFOX chemotherapy regimens who showed a dramatic and durable response to bevacizumab and FOLFIRI. We also review and discuss the available literature.

5.
Can J Gastroenterol ; 14 Suppl D: 181D-184D, 2000 Nov.
Artículo en Francés | MEDLINE | ID: mdl-11110632

RESUMEN

Ascites are common in malignancies of the gastrointestinal tract but are rarely associated with chronic lymphoid leukemia. An unusual progression of chronic lymphoid leukemia, rapidly complicated with ascites, is presented, followed by a discussion of the causes and types of ascites found in solid and blood malignancies.


Asunto(s)
Ascitis/etiología , Leucemia Linfocítica Crónica de Células B/complicaciones , Ascitis/patología , Progresión de la Enfermedad , Resultado Fatal , Humanos , Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico , Leucemia Linfocítica Crónica de Células B/patología , Hígado/patología , Masculino , Persona de Mediana Edad
6.
Am J Hematol ; 50(3): 188-99, 1995 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-7485080

RESUMEN

This report reviews the diagnostic significance of immune markers, their relationship to patient outcome, and the therapeutic uses of monoclonal antibodies (MoAbs) in acute leukemia. Immunophenotyping allows for rapid and reproducible diagnosis in the majority of cases of acute leukemia. It is of particular importance in recognizing the major immunologic subclasses of acute lymphoblastic leukemia (ALL), and in identifying subtypes of acute myeloblastic leukemia (AML) which cannot be differentiated by morphology and cytochemistry alone, such as FAB M0 or M7. Immune marker analysis has been used to detect minimal residual disease in patients' bone marrow and CSF after treatment. However, the presence of leukemia-associated phenotypes on small numbers of normal cells may reduce the sensitivity of detection in some cases. The prognostic value of immune markers in AML is limited. In ALL, the prognostic significance of the different immunophenotypic subtypes has been lessened by modern treatment protocols. The relationship of mixed-lineage or biphenotypic antigen expression to patient outcome in both AML and ALL is unclear. Therapeutic applications of MoAbs in acute leukemia include immunologic techniques for purging malignant cells from autografts prior to transplantation, T-lymphocyte depletion from allografts as a strategy to reduce graft-versus-host disease, and the use of flow cytometry to monitor the timing and extent of leukapheresis in peripheral stem cell transplantation. MoAbs have also enabled the recent development of transplantation protocols using positively-selected CD34+ stem cells.


Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Leucemia Mieloide Aguda/diagnóstico , Leucemia Mieloide Aguda/terapia , Leucemia/diagnóstico , Leucemia/terapia , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico , Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia , Enfermedad Aguda , Antígenos CD34/análisis , Trasplante de Células Madre Hematopoyéticas/métodos , Humanos , Inmunofenotipificación , Inmunoterapia , Neoplasia Residual/diagnóstico , Pronóstico
11.
Hematol Pathol ; 5(4): 177-83, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1794967

RESUMEN

The estimated S-phase fraction (%S) of non-Hodgkin's lymphomas has been demonstrated to be of prognostic value. The %S can be determined by labeling index (LI) techniques or by various mathematical models applied to DNA content histograms. We performed DNA content analysis and a slide-based bromodeoxyuridine immunofluorescence LI on split samples from 117 biopsy specimens suspicious for lymphoma. The LI was compared with the %S determined by two computer models (rectangular and polynomial) with and without debris subtraction, and a manual gates computer model. In the 93 DNA diploid cases, the rectangular models had the highest correlation with the LI (R = 0.88). In the 24 aneuploid cases, the manual gates model was the most useful because of a high correlation with the LI (R = 0.70) and its ability to be used in most cases (23/24). The polynomial models had limited usefulness because they generally gave a higher %S than the LI and could be fitted in less than half of the DNA aneuploid histograms. These results suggest that in situations where the LI is not possible, an accurate %S estimate can usually be obtained with either a rectangular or manual gates model.


Asunto(s)
Bromodesoxiuridina , ADN de Neoplasias/análisis , Linfoma no Hodgkin/genética , Modelos Genéticos , Fase S/fisiología , Citometría de Flujo , Humanos , Cinética , Linfoma no Hodgkin/patología , Pronóstico , Estudios Retrospectivos
12.
J Electron Microsc Tech ; 10(2): 211-2, 1988 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-3230414

RESUMEN

A simple procedure is described for the preparation of a totally inorganic, durable, strongly bonded, and non-shrinking phosphor viewing screen. The procedure requires no special apparatus or skills in order to prepare a fairly uniform high resolution screen in only about 0.5 hours plus drying time. The screens are suitable for use on an automatic exposure system where mechanical shock can destroy a screen.


Asunto(s)
Microscopía Electrónica/instrumentación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA